Self-poisoning with paracetamol, alone or in combination with other drugs, is an increasing problem in the Eastern Region of Scotland as elsewhere (Prescott et al., 1971) .
The investigation of such cases is, at present, slanted towards prognosis rather than treatment, as, despite efforts at treatment with steroids, forced alkaline diuresis and peritoneal dialysis (MacLean et al., 1968; Prescott et al., 197\) , exchange transfusion (Pimstone and Uys, 1968 ) and haemodialysis (Farid et al., 1972) , no active measures have yet emerged which can radically alter the amount of liver damage which occurs in serious cases.
A rapid guide as to the likelihood of liver damage is helpful in these cases as clinical jaundice and biochemical signs of liver damage may not become evident until two or three days after the overdose, by which time a patient may well have been discharged.
Early reports from the Edinburgh Poisoning Treatment Centre (Proudfoot and Wright, 1970) showed that the amount of liver damage in paracetamol self-poisoning correlated well with the number of tablets taken. Unfortunately, the accurate assessment of the number, from the patient or relatives, is often difficult (Matthew, 1971; Kerr, Patients 1972) . Brown et al. (1969) showed that liver damage can Thirty cases of poisoning with paracetamol, alone be expected if paracetamol can be detected in the or in combination with other drugs, have been plasma 24 h after ingestion, and Proudfoot and admitted to the wards served by this laboratory in Wright (1970), and Prescott et al. (1971) later showed the past year. Two of the cases were fatal. One had good correlation between liver damage and plasma taken 50 'distalgesic' tablets (paracetamol and paracetamol concentration 4 hand 12 h after dextropropoxyphene) along with amylobarbitone ingestion. They also showed that an equally valid and a considerable amount of alcohol. The other had indication could be obtained from the half-life of taken only paracetamol. Of the other 28 cases, all paracetamol in the plasma; a half-life greater than were discharged well, although nine showed bio-4 h being a grave prognostic sign. After two or three chemical evidence of acute liver damage. Two of days, the extent of the acute liver damage can be these cases had taken amylobarbitone and eight had assessed by determining serum aspartate amino-taken alcohol although only one had taken a large transferase (AST) or alanine aminotransferase amount (more than 5 pints, 2.8 I, of beer). One (AL T) activity (Brown et al., 1969) Brown et al. (1969) , Prescott et al. (1971) and Proudfoot and Wright (1970) who found that a paracetamol concentration greater than 300 rngj] 4 h after taking the tablets was a grave prognostic sign, as were a concentration greater than 50 rng/l at 12 h or any detectable paracetamol at 24 h. In their series no patient with a 4 h level Jess than 120 mg/I suffered acute liver damage. The figure shows that, using the dotted line as a guide, we were able to predict the likelihood Qf liver damage correctly in all but one border-line case. This case did suffer some liver damage and the AST rose to four times the upper limit of normal on the third day. Most important is that in no case where the level(s) lay to the left of the prediction line, no matter at what time they were determined, was there any biochemical evidence of liver damage, and neither enlargement of the liver nor clinical jaundice were observed.
In a further 13 cases (not shown on the graph), all with a history of having taken up to 20 tablets of paracetamol, panadol or distalgesic, the earliest blood specimen obtained (in all cases at less than] 2 h after ingestion) there was no detectable paracetamol in the plasma. These negative results, therefore, also fall to the left of the prediction line. In none of these cases was there a rise in AST level.
The rise and fall in serum AST activity in these cases can be so rapid that it is easy to miss the peak of activity. Brown et 01. (1969) state that the AL T peak occurs at three to five days after ingestion of paracetamoI. In our series, all patients except one showed a peak in AST before the fifth day. The exception was the fatal case (MB) discussed below. The AST activities in the two fatal and the five most The relationship between plasma paracetamol concentrations at different times, and the outcome in terms of liver damage is shown for 17 patients in 
Assessment of liver function
Serum was analysed as follows on admission and then daily for four days, after which the frequency was reduced.
I. AST, HBD, gammaglutamyltranspeptidase by ultra-violet kinetic methods.
2. Total protein, albumin, bilirubin and alkaline phosphatase by SMA 12/60 methods.
3. LDH isoenzymes were measured only in those cases where the HBD and AST levels were greatly elevated, in order to exclude a cardiac source for these enzymes.
4. Cholinesterase (King, 1965) . Alanine aminotransferase and LDH are not normally determined in this laboratory for the reasons stated by Salkie (1971) .
RESULTS
mol overdose, but no biochemical or toxicological data were available for this admission.
Biochemical investigations
Plasma paracetamol concentration was determined by the method of Routh et al, (1968) and later by the modification of Gibson (1972) . Plasma was obtained, at the earliest opportunity, from all patients with a history of paracetamol ingestion or from those whose urine showed a positive screening test for p-aminophenol on admission following overdose with an unknown drug. Further analyses were made at regular intervals, in patients in whom the drug was found, until the level was below the limits of detection (10 rng/l), Blood was analysed for barbiturates during normal laboratory hours by gas chromatography on a 10% apiezon L column (Leach and Toseland, 1968 ) and outside these times by the ultra-violet spectrophotometric method of Broughton (1956) . All specimens were screened for salicylate by the method of Keller (1947) .
Plasma urea and plasma electrolytes were determined on admission and thereafter only if indicated by the clinical condition. Blood sugar was determined by an automated Neocuproine method modified from Brown (1961) and Bitner and McCleary (1963) only if there was clinical suspicion of hypoglycaemia: no values were found below 60 mg/ 100 ml.
Other tests of liver function
Serum total protein and albumin concentrations serious non-fatal cases are shown in Fig. 2 . The remainder of the patients had smaller rises in AST activity and none showed biochemical evidence of chronic liver damage subsequently. In view of the fact that the patient with the highest AST activity recovered uneventfully, caution must be exerted in attaching weight to the absolute level of AST for prognostic purposes.
An abnormal ECG was recorded in only one patient who died after four days having bled from the gastro-intestinal tract.
In three other cases where the serum AST and HBD activities were grossly elevated, LDH isoenzyme studies showed raised LD4 and 5. In none of the four most serious cases was there any evidence of a rise in the cardiac isoenzyme.
The patient mentioned above, who suffered multiple haemorrhages, was oliguric following the haemorrhage until death. The other fatal case, M B, in whom the blood urea rose to 200 mgjl 00 ml one week after admission, and fell to 52 mgflOO ml in the next week, was the only other case with abnormal renal function.
Renal function
Cardiac involvement did not change in the acute phase in any of the patients, and only fell after five days in one of the fatal cases. The same picture was found with cholinesterase.
Serum bilirubin was elevated after two or three days in both fatal cases, 50 %of severe cases and 30 % of mild cases. In no case was the rise greater than five times the upper limit of normal. Serum alkaline phosphatase and 5' nucleotidase levels were elevated only in two cases. one fatal and the other serious. In the other fatal case, the patient died of a haemorrhage before the time at which a rise in these enzymes would have been expected .
The assay of plasma gammaglutamyltranspeptidase became available in this laboratory towards the end of the series. In all three patients in whom it was measured (two serious and one mild case) there was a slow rise in gammaglutamyltranspeptidase. The rise in the serious cases was up to eight times normal and the mild case rose to three time the upper limit of normal. Both serious cases still showed rising levels on discharge, but we were unfortunately unable to follow up these patients.
Plasma prothrombin times were abnormal in all serious and fatal cases within 24 h. The results of this test enabled clinical decisions to be made. and in general, the greater the abnormality the worse the prognosis. The patient who died after four days had an unrecordable prothrombin time from day 2 and suffered multiple haemorrhages from the gastrointestinal tract. All patients in whom the prothrombin time was abnormal were treated with vitamin K. concentration fell to 20 mg/1. The paracetamol was detectable in the plasma for 150 h after the stated time of overdose. The most relevant liver function test results are shown in Fig. 4 . The rise in serum bilirubin was matched by the deepening jaundice which persisted until her death 30 days after admission. The peak in AST activity was not as high as in previously reported non-fatal cases, but it occurred later (five days after the dose) than in any other of our cases. The presence or absence of bowel sounds was not recorded, but it is tempting to assume that absorption of paracetamol from the gut may have been slower following sedation with the amylobarbitone. The fortuitous occurrence of three cases of overdose with both amylobarbitone and paracetamol has allowed us to compare the hydroxylating capacity of the liver in the three patients, one fatal, one severe and one mild.
The results are shown in Fig. 3 and demonstrate that in the mild and severe cases there was sufficient undamaged liver to metabolise the barbiturate normally, but that in the fatal case the rate of metabolism was greatly reduced. The amylobarbitone concentration in the plasma of this patient fluctuated following alterations in plasma volume following fluid therapy, but the overall picture is of a greatly prolonged amylobarbitone half-life. These three results illustrate the extent of the fall in the metabolic capacity of the liver in cases of druginduced acute hepatic damage.
Results obtained in a fatal case of paracetumol poisoning
The patient, M. B., a 30-year-old woman, was admitted after having taken 50 distalgesic tablets (approx. 15 g paracetamol), amylobarbitone, and alcohol equivalent to half a bottle of whisky. She was in grade 4 coma. Routine 'on admission' analyses showed a blood amylobarbitone concentration of 34 mg/l, The first plasma paracetamol concentration, 36 h after the overdose, was 120 mg/1. Gastric lavage had been performed and she was treated conservatively for the barbiturate overdose. Hydrocortisone was given. The coma persisted for seven days, during which the amylobarbitone Prothrombin times were consistently abnormal although she was treated with vitamin K from the outset. Figure 4 shows the initial acute phase, a partial recovery, and the development of both intrahepatic obstruction, as shown by the bilirubin and alkaline phosphatase levels and, later, a fall in the synthetic capacity of the liver as demonstrated by the gradual fall in serum albumin and cholinesterase.
DISCUSSION
The results from this series of patients poisoned with paracetamol support the observations of the Edinburgh group. All patients with 4 h plasma con-centrations of paracetamol greater than 200 mg/I showed liver damage, and none of those with concentrations less than 120 mg/I had biochemical or clinical evidence of liver damage. All of those with a concentration greater than 50 mg/I at 12 h or detectable levels at 24 h showed liver damage-in two cases with fatal outcome.
Although we, and previous authors, have routinely measured several liver function tests in cases of paracetamol overdose, it is becoming clear that this has little advantage over the use of selected tests. The AST or ALT must be measured from the time of first admission, prothrombin times are essential as are the levels of paracetamol. We are less convinced of the necessity for other enzymes with the exception of gammaglutamyltranspeptidase which seems to remain raised for a much longer time than others and may be worth measuring in long term follow up. We have, unfortunately, not been able to keep in contact with those patients in whom this analysis was carried out during admission.
It has been stated (Prescott et al., 1971 ) that the increased half-life of plasma paracetamol concentration which occurs in severe overdose is due to the damage caused to the hepatocyte by the first pass of the paracetamol through the liver. Certain other factors have been thought of as possibly increasing the sensitivity of the liver to paracetamol. Notable among these are alcohol and concurrent ingestion of other drugs. In our three cases with a prolonged half-life, two had taken significant amounts of alcohol and one had not taken any. In view of the evidence of Mitchell et al. (1972) that the liver damage is caused by or during the oxidation of paracetamol, it may be that alcohol can increase the damage caused by introducing a further demand on the oxidising capacity of the liver cell.
In one of our cases with a prolonged half-life and severe liver damage (AST 180 times upper limit of normal), there had been a previous attempt at selfpoisoning with paracetamol, and in this case the damage was greater than would have been expected from the number of tablets stated to have been taken. It is tempting to assume that in this case there was some residual impairment in liver cell metabolism.
Ofthe three patients with a low rate of metabolism, and a severe outcome, only one had nothing in the past history to indicate possible liver damage. The liver function tests on admission were normal, and there was no evidence of ingestion of alcohol or other drugs. In this patient the prognosis suggested by the paracetamol levels was poor.
The techniques for screening urine for paracetamol or its metabolite p-aminophenol are simple and are routine in this department (Simpson and Stewart, 177 1973) . The determination of plasma paracetamol requires an ultra-violet spectrophotometer, available in most laboratories, yet many general hospital laboratories do not yet offer this analysis. Indeed recent reports such as that of Lawson and Mitchell (1972) would suggest that the analysis of drugs other than barbiturate and salicylate are of little concern to the physician in the peripheral hospital.
We are particularly concerned about preparations which contain salicylate and paracetamol. These may give rise to some cases of combined overdose with these drugs where the lethal potential of the paracetamol may well be missed due to the clear indications of salicylate overdose. In addition, the anti-diuretic effect of the metabolites of paracetamol may well complicate the standard procedure of forced alkaline diuresis in such cases. We would advocate that urine is screened for p-aminophenol in all cases of overdose to avoid possible mistakes.
In severe overdose with paracetamol the patient may feel well on the day after ingestion and possibly on the subsequent day. In this respect the patient who has taken an hypnotic may give the clinician less problems in that, by the time recovery from the hypnotic occurs, the biochemical sequelae, if any, of the paracetamol may have started to become obvious. The length of coma due to even a small dose of barbiturate can be greatly prolonged if paracetamol is also taken, as was seen in the case of M.B. detailed above, who suffered such acute liver damage as to be unable to metabolise the small amount of amylobarbitone taken, and remained in coma for six days.
It is hoped that this report, from a region which does not have a poisoning treatment centre, will encourage those in similar areas to introduce the determination of paracetamol in cases of selfpoisoning. The provision of this prognostic index should avoid the twin errors of premature discharge of the severe case and unnecessary retention of the mild overdose.
